Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.
The European respiratory journal · 2023 · 1,068 citations · Bartolome Celli
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.
American journal of respiratory and critical care medicine · 2023 · 597 citations · Bartolome Celli
The global burden of COPD: epidemiology and effect of prevention strategies.
The Lancet. Respiratory medicine · 2025 · 135 citations · Bartolome Celli
Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision.
American journal of respiratory and critical care medicine · 2022 · 416 citations · Bartolome Celli
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial.
Journal of the American Academy of Dermatology · 2023 · 292 citations · Subhashis Banerjee
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter.
Neuro-oncology · 2022 · 470 citations ·
COPD and multimorbidity: recognising and addressing a syndemic occurrence.
The Lancet. Respiratory medicine · 2023 · 241 citations · Bartolome Celli
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial.
Journal of the American Academy of Dermatology · 2023 · 241 citations · Subhashis Banerjee